Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2016-10-04, 09:33:57 | version 1.38.0
Nobel Biocare Global Symposium meetings | 59 CAD/CAM 3 2016 Brexit remain unclear. I believe that even experts cannot predict the impact of the Brexit on the in- dustry. From a personal point of view, I believe it is never a good thing to have many separate markets. However, whether the Brexit will affect us as Nobel Biocare directly, I do not yet know. How has the acquisition by the dental platform of the Danaher Corporation, which occurred at the end of 2014, affected Nobel Biocare’s busi- ness? We have seen only positive effects. The transition into the dental platform has given us new opportu- nities to develop resources for innovation, market- ing and sales that we would not have had without this partnership. Collaboration with other brands within the platform has granted access to expertise that is allowing us to lead innovation in dentistry. We are learning from our colleagues and have gained tools that are helping us to refine our pro- cesses and accelerate results. The new home of Nobel Biocare is a very good one. The next big occasion in the dental event sched- ule is the International Dental Show in March next year. Are there even more innovations to come from Nobel Biocare? Icannotdiscloseanythingyet.However,Icantellyou already that there will be significant innovations presented. The potential that we are going to bring to the market will be of the same magnitude as that experienced at the symposium over the past few days. Nobel Biocare will accelerate its delivery of significantandmeaningfulinnovations,eachdevel- oped with the well-being of the patient in mind._ 32016